
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
TLX3
Introduction
T-cell leukemia homeobox protein 3 is a protein that in humans is encoded by the TLX3 gene.[1][2][3]
RNX (HOX11L2, TLX3) belongs to a family of orphan homeobox genes that encode DNA-binding nuclear transcription factors. Members of the HOX11 gene family are characterized by a threonine-47 replacing cytosine in the highly conserved homeodomain (Dear et al., 1993).[supplied by OMIM][3]
References
References
- ↑ Lee-Kirsch MA, Engel K, Paditz E, Rosen-Wolff A, Lee YA, Gahr M (Jul 2001). “Assignment of the human homeobox 11-like 2 gene (HOX11L2) to chromosome 5q34→q35 by radiation hybrid mapping”. Cytogenet Cell Genet. 92 (3–4): 358. doi:10.1159/000056933. PMID 11435718.
- ↑ Cinti R, Fava M, Sancandi M, Matera I, Ravazzolo R, Ceccherini I (Jul 2001). “Assignment of the HOX11L2 gene to human chromosome band 5q35.1 and of its murine homolog to mouse chromosome bands 11A4-A5 by in situ hybridization”. Cytogenet Cell Genet. 92 (3–4): 354–5. doi:10.1159/000056931. PMID 11435716.
- ↑ 3.0 3.1 “Entrez Gene: TLX3 T-cell leukemia homeobox 3”.
Further reading
Further reading
- Dear TN, Sanchez-Garcia I, Rabbitts TH (1993). “The HOX11 gene encodes a DNA-binding nuclear transcription factor belonging to a distinct family of homeobox genes”. Proc. Natl. Acad. Sci. U.S.A. 90 (10): 4431–5. doi:10.1073/pnas.90.10.4431. PMC 46525. PMID 8099440.
- Bernard OA, Busson-LeConiat M, Ballerini P, et al. (2002). “A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia”. Leukemia. 15 (10): 1495–504. doi:10.1038/sj.leu.2402249. PMID 11587205.
- Ballerini P, Blaise A, Busson-Le Coniat M, et al. (2002). “HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis”. Blood. 100 (3): 991–7. doi:10.1182/blood-2001-11-0093. PMID 12130513.
- Matera I, Bachetti T, Cinti R, et al. (2003). “Mutational analysis of the RNX gene in congenital central hypoventilation syndrome”. Am. J. Med. Genet. 113 (2): 178–82. doi:10.1002/ajmg.10746. PMID 12407709.
- Mauvieux L, Leymarie V, Helias C, et al. (2003). “High incidence of Hox11L2 expression in children with T-ALL”. Leukemia. 16 (12): 2417–22. doi:10.1038/sj.leu.2402709. PMID 12454747.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Berger R, Dastugue N, Busson M, et al. (2003). “t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH)”. Leukemia. 17 (9): 1851–7. doi:10.1038/sj.leu.2403061. PMID 12970786.
- Cavé H, Suciu S, Preudhomme C, et al. (2004). “Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951”. Blood. 103 (2): 442–50. doi:10.1182/blood-2003-05-1495. PMID 14504110.
- Su XY, Busson M, Della Valle V, et al. (2004). “Various types of rearrangements target TLX3 locus in T-cell acute lymphoblastic leukemia”. Genes Chromosomes Cancer. 41 (3): 243–9. doi:10.1002/gcc.20088. PMID 15334547.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Ballerini P, Busson M, Fasola S, et al. (2005). “NUP214-ABL1 amplification in t(5;14)/HOX11L2-positive ALL present with several forms and may have a prognostic significance”. Leukemia. 19 (3): 468–70. doi:10.1038/sj.leu.2403654. PMID 15674415.
- Gottardo NG, Jacoby PA, Sather HN, et al. (2005). “Significance of HOX11L2/TLX3 expression in children with T-cell acute lymphoblastic leukemia treated on Children’s Cancer Group protocols”. Leukemia. 19 (9): 1705–8. doi:10.1038/sj.leu.2403834. PMID 15990867.
- Borghini S, Vargiolu M, Di Duca M, et al. (2006). “Nuclear factor Y drives basal transcription of the human TLX3, a gene overexpressed in T-cell acute lymphocytic leukemia”. Mol. Cancer Res. 4 (9): 635–43. doi:10.1158/1541-7786.MCR-05-0250. PMID 16966433.
- Nagel S, Scherr M, Kel A, et al. (2007). “Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3′-BCL11B enhancers and coregulation by PU.1 and HMGA1”. Cancer Res. 67 (4): 1461–71. doi:10.1158/0008-5472.CAN-06-2615. PMID 17308084.
